Literature DB >> 21225455

Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.

Julia Kravchenko1, Igor Akushevich, Victoria L Seewaldt, Amy P Abernethy, H Kim Lyerly.   

Abstract

The observed bimodal patterns of breast cancer incidence in the U.S. suggested that breast cancer may be viewed as more than one biological entity. We studied the factors potentially contributing to this phenomenon, specifically focusing on how disease heterogeneity could be linked to breast carcinogenesis mechanisms. Using empirical analyses and population-based biologically motivated modeling, age-specific patterns of incidence of ductal and lobular breast carcinomas from the SEER registry (1990-2003) were analyzed for heterogeneity and characteristics of carcinogenesis, stratified by race, stage, grade, and estrogen (ER)/progesterone (PR) receptor status. The heterogeneity of breast carcinoma age patterns decreased after stratification by grade, especially for grade I and III tumors. Stratification by ER/PR status further reduced the heterogeneity, especially for ER(+)/PR(-) and ER(-)/(-) tumors; however, the residual heterogeneity was still observed. The number of rate-limiting events of carcinogenesis and the latency of ductal and lobular carcinomas differed, decreasing from grade I to III, with poorly differentiated tumors associated with the least number of carcinogenesis stages and the shortest latency. Tumor grades play important role in bimodal incidence of breast carcinoma and have distinct mechanisms of carcinogenesis. Race and cancer subtype could play modifying role. ER/PR status contributes to the observed heterogeneity, but is subdominant to tumor grade. Further studies on sources of "remaining" heterogeneity of population with breast cancer (such as genetic/epigenetic characteristics) are necessary. The results of this study could suggest stratification rather than unification of breast cancer prevention strategies, risk assessment, and treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225455     DOI: 10.1007/s10549-011-1347-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?

Authors:  Morten Valberg; Tom Grotmol; Steinar Tretli; Marit B Veierød; Tron A Moger; Susan S Devesa; Odd O Aalen
Journal:  Eur J Epidemiol       Date:  2016-07-18       Impact factor: 8.082

Review 2.  Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions.

Authors:  Julia Kravchenko; Emanuela Corsini; Marc A Williams; William Decker; Masoud H Manjili; Takemi Otsuki; Neetu Singh; Faha Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson; Leroy Lowe; H Kim Lyerly
Journal:  Carcinogenesis       Date:  2015-05-22       Impact factor: 4.944

3.  New stochastic carcinogenesis model with covariates: an approach involving intracellular barrier mechanisms.

Authors:  Igor Akushevich; Galina Veremeyeva; Julia Kravchenko; Svetlana Ukraintseva; Konstantin Arbeev; Alexander V Akleyev; Anatoly I Yashin
Journal:  Math Biosci       Date:  2011-12-17       Impact factor: 2.144

Review 4.  Current Status of Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer.

Authors:  Tomás Reinert; Rodrigo Gonçalves; Matthew J Ellis
Journal:  Curr Treat Options Oncol       Date:  2018-04-16

5.  What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?

Authors:  Dora Il'yasova; Sharareh Siamakpour-Reihani; Igor Akushevich; Lucy Akushevich; Neil Spector; Joellen Schildkraut
Journal:  Breast Cancer Res Treat       Date:  2011-08-18       Impact factor: 4.872

6.  Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 years.

Authors:  Morten Valberg; Tom Grotmol; Steinar Tretli; Marit B Veierød; Susan S Devesa; Odd O Aalen
Journal:  Stat Med       Date:  2012-06-29       Impact factor: 2.373

7.  Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses.

Authors:  Michael X Gleason; Tengiz Mdzinarishvili; Simon Sherman
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.

Authors:  Julia Kravchenko; Igor Akushevich; Amy P Abernethy; H Kim Lyerly
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

9.  Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.

Authors:  Grace O Silva; Xiaping He; Joel S Parker; Michael L Gatza; Lisa A Carey; Jack P Hou; Stacy L Moulder; Paul K Marcom; Jian Ma; Jeffrey M Rosen; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2015-06-25       Impact factor: 4.872

10.  Basic equations and computing procedures for frailty modeling of carcinogenesis: application to pancreatic cancer data.

Authors:  Tengiz Mdzinarishvili; Simon Sherman
Journal:  Cancer Inform       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.